J. Takahashi

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Y. Hasebe1
N. Shiba1
H. Shioiri1
1Y. Hasebe
1N. Shiba
1H. Shioiri
Learn More
We examined whether an additive treatment with an angiotensin receptor blocker, olmesartan, reduces the mortality and morbidity in hypertensive patients with chronic heart failure (CHF) treated with angiotensin-converting enzyme (ACE) inhibitors, β-blockers, or both. In this prospective, randomized, open-label, blinded endpoint study, a total of 1147(More)
  • 1